Regulation of pharmacy ownership

This Regulatory Impact Statement sets out the analysis produced to inform Cabinet decisions on regulation of pharmacy ownership under the Medical Products Bill.

Cabinet material and decisions relating to this Regulatory Impact Statement can be found at: Cabinet Material - Medical Products Bill: Reducing Regulation and Other Policy Matters.